Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Perkins

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Diabetes Research and Clinical Practice|November 30, 2023
Ketone production and excretion even during mild hyperglycemia and the impact of sodium-glucose co-transporter inhibition in type 1 diabetesDaniel Scarr, Erik Lovblom, Hongping Ye, et al.
Plos One|November 6, 2015
Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor PolyneuropathyIlia Ostrovski, Leif E Lovblom, Mohammed A Farooqi, et al.
Circulation|December 17, 2013
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitusDavid Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 1, 2016
Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC StudyIan H de Boer, Xiaoyu Gao, Patricia A Cleary, et al.
Diabetes Care|September 22, 2011
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phaseRichard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
Diabetes Care|July 9, 2026
Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 DiabetesMohammad I Abuabat, Dalton Budhram, Priya Bapat, et al.
BMJ Open Diabetes Research & Care|November 28, 2017
Biomarkers of tubulointerstitial damage and function in type 1 diabetesIan H de Boer, Xiaoyu Gao, Ionut Bebu, et al.
Ebiomedicine|December 6, 2025
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathyAjith Sivadasan, Paul Fernyhough, Nigel A Calcutt, et al.
Kidney International Reports|May 6, 2024
Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 DiabetesChristine P Limonte, Xiaoyu Gao, Ionut Bebu, et al.
Cardiovascular Diabetology|January 27, 2016
Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohortJohnny W Bai, Geneviève Boulet, Elise M Halpern, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Diabetes Research and Clinical Practice|November 30, 2023
Ketone production and excretion even during mild hyperglycemia and the impact of sodium-glucose co-transporter inhibition in type 1 diabetesDaniel Scarr, Erik Lovblom, Hongping Ye, et al.
Plos One|November 6, 2015
Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor PolyneuropathyIlia Ostrovski, Leif E Lovblom, Mohammed A Farooqi, et al.
Circulation|December 17, 2013
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitusDavid Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 1, 2016
Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC StudyIan H de Boer, Xiaoyu Gao, Patricia A Cleary, et al.
Diabetes Care|September 22, 2011
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phaseRichard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
Diabetes Care|July 9, 2026
Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 DiabetesMohammad I Abuabat, Dalton Budhram, Priya Bapat, et al.
BMJ Open Diabetes Research & Care|November 28, 2017
Biomarkers of tubulointerstitial damage and function in type 1 diabetesIan H de Boer, Xiaoyu Gao, Ionut Bebu, et al.
Ebiomedicine|December 6, 2025
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathyAjith Sivadasan, Paul Fernyhough, Nigel A Calcutt, et al.
Kidney International Reports|May 6, 2024
Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 DiabetesChristine P Limonte, Xiaoyu Gao, Ionut Bebu, et al.
Cardiovascular Diabetology|January 27, 2016
Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohortJohnny W Bai, Geneviève Boulet, Elise M Halpern, et al.
Pageof 25